ACA vs WST · P/E 57, rev $2.88B vs P/E 35, rev $2.89B
Arcosa Inc (ACA) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the ACA and WST stock pages for the full models.
Not investment advice.